Interestingly, overexpression of CD36 can be driven by multiple risk factors of NAFLD, including insulin resistance, hyperinsulinemia, and hepatitis C virus (HCV) infection [41]. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.